Skip to main content
. 2015 Apr 9;7(2):128–134. doi: 10.5114/jcb.2015.50720

Table 6.

Survival outcomes due to stage

Current study Foundation for promotion of cancer research in Japan 2005 Guideline of radiation therapy in Japan 2008 The committee of gynecologic oncology of Japan 2004
3y OS 3y OS 5y OS 5y OS
All stage 69% 81%
Stage I 100% 90% 80-90% 82.3%
Stage II 73% 83% 60-80% 61.4%
Stage III 57% 65% 40-60% 37.6%
Stage IV 59% 36% (stage IVA) 10-40% 12.6%

OS – overall survival